Las Vegas, NV -- (SBWIRE) -- 10/31/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Integrated Device Technology Inc (NASDAQ:IDTI), Cerus Corporation (NASDAQ:CERS), Newcastle Investment Corp. (NYSE:NCT), Synta Pharmaceuticals Corp. (NASDAQ:SNTA)
Integrated Device Technology Inc (NASDAQ:IDTI) managed to keep its gain at 0.38% on above-normal volume of 2.42M shares. The stock settled at $10.64 after floating in a range of $10.54 to $10.85. Its latest price has reached market capitalization of $1.59 billion. Its 52-week range has been $5.30 to $11.36. Integrated Device Technology, Inc. (IDT) designs, develops, manufactures and markets a range of semiconductor solutions for the advanced communications, computing and consumer industries. The Company offers communications solutions for customers within the enterprise, data center and wireless markets.
For How Long IDTI will fight for Profitability? Read This Trend Analysis report
Cerus Corporation (NASDAQ:CERS) traded down on a volume of 2.42 million, higher than its standard daily volume. Shares have dropped-9.08% to $6.31. Over the last twelve months, the stock has gained 99.05% and faced a worst price of $2.68. Cerus Corporation is a biomedical products company focused on commercializing the INTERCEPT Blood System to enhance blood safety.
Has CERS Found The Bottom And Ready To Gain Momentum? Find Out Here
Newcastle Investment Corp. (NYSE:NCT) settled -0.52% lower at $5.77 on below -normal volume of 2.35M shares during the last trading day. The stock has its 12-month high at $12.49 and 52-week low price was $4.70. It traded in a range of $5.67 to $5.80 during the last trading day. Newcastle Investment Corp. (Newcastle) is a real estate investment and finance company. Newcastle invests in, and actively manages, a portfolio of, real estate securities, loans, excess mortgage servicing rights (MSRs) and other real estate related assets.
Will NCT Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Synta Pharmaceuticals Corp. (NASDAQ:SNTA) was down on high volume, trading at a volume of 2.34M versus its average daily volume of 1.30 million shares. At $4.43, the stock has attained market capitalization of 305.93 million. Synta Pharmaceuticals Corp. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing small molecule drugs to severe the medical conditions of the patients with cancer and inflammatory diseases.
Why Should Investors Buy SNTA After the Recent Fall? Just Go Here and Find Out
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)